Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomised Controlled Trial Comparing Convergent Hybrid Ablation to Catheter Ablation in Patients With Persistent Atrial Fibrillation and Heart Failure

NCT05411614 is registered in ClinicalTrials.gov with St. George's Hospital, London as lead sponsor.

NCT NCT05411614
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05411614 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomised Controlled Trial Comparing Convergent Hybrid Ablation to Catheter Ablation in Patients With Persistent Atrial Fibrillation and Heart Failure
Lead sponsor
St. George's Hospital, London
Phase
Not applicable
Overall status
Recruiting
Start date
June 25, 2022
Completion date
October 31, 2027
Enrollment
120 (estimated)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

atrial arrhythmia, atrial fibrillation, atrial fibrillation, persistent, heart failure, left ventricular (lv) systolic dysfunction, persistent atrial fibrillation